Aptuit, Inc. has agreed to acquire Evotec AG’s Chemical and Pharmaceutical Development (CPD) business, which includes an API facility in Oxford, England and a recently-expanded parenteral fill/finish facility in Glasgow, Scotland. The acquisition provides Aptuit with an established European presence in API development services. The CPD business provides small molecule API development labs, kilo labs and pilot plants as well as clinical scale parenteral fill/finish including two lyophilizat...